statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
NA - Nord America	3.913
EU - Europa	3.480
AS - Asia	2.598
SA - Sud America	394
AF - Africa	54
OC - Oceania	10
Continente sconosciuto - Info sul continente non disponibili	2
Totale	10.451

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	3.759
IT - Italia	2.242
SG - Singapore	1.329
HK - Hong Kong	499
CN - Cina	368
BR - Brasile	347
GB - Regno Unito	267
DE - Germania	183
RU - Federazione Russa	173
IE - Irlanda	154
VN - Vietnam	104
UA - Ucraina	89
CA - Canada	87
FI - Finlandia	83
IN - India	76
TR - Turchia	76
SE - Svezia	71
MX - Messico	54
JP - Giappone	41
AT - Austria	38
FR - Francia	38
PL - Polonia	35
BD - Bangladesh	29
NL - Olanda	26
ES - Italia	23
ZA - Sudafrica	23
AR - Argentina	19
IQ - Iraq	18
LT - Lituania	18
BE - Belgio	17
AE - Emirati Arabi Uniti	10
CH - Svizzera	9
AU - Australia	8
EC - Ecuador	7
MA - Marocco	7
SA - Arabia Saudita	7
KE - Kenya	6
CL - Cile	5
CO - Colombia	5
EG - Egitto	5
ID - Indonesia	5
MY - Malesia	5
TN - Tunisia	5
VE - Venezuela	5
IL - Israele	4
JO - Giordania	4
PK - Pakistan	4
BB - Barbados	3
CI - Costa d'Avorio	3
LB - Libano	3
NO - Norvegia	3
TT - Trinidad e Tobago	3
AZ - Azerbaigian	2
BH - Bahrain	2
CR - Costa Rica	2
CZ - Repubblica Ceca	2
EU - Europa	2
GT - Guatemala	2
IR - Iran	2
KR - Corea	2
PY - Paraguay	2
RS - Serbia	2
RW - Ruanda	2
UY - Uruguay	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
BG - Bulgaria	1
BY - Bielorussia	1
BZ - Belize	1
CG - Congo	1
DK - Danimarca	1
EE - Estonia	1
ET - Etiopia	1
GE - Georgia	1
GY - Guiana	1
HN - Honduras	1
IM - Isola di Man	1
KZ - Kazakistan	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TO - Tonga	1
UZ - Uzbekistan	1
Totale	10.451

Salva come PNG Salva come JPEG

Città	#
Milan	1.394
Singapore	665
Hong Kong	496
Ashburn	451
Dallas	447
Chicago	281
Beijing	216
Boardman	213
London	174
Dublin	150
Los Angeles	149
Fairfield	141
Rome	123
The Dalles	109
Chandler	94
Varese	92
Seattle	79
Jacksonville	72
Munich	71
New York	67
Como	60
Houston	58
Santa Clara	57
Woodbridge	55
Salt Lake City	53
Wilmington	52
Ogden	49
Washington	43
Brooklyn	42
Ann Arbor	41
Toronto	38
Tokyo	36
Nyköping	35
Cambridge	32
Tampa	32
Warsaw	32
São Paulo	31
Chennai	30
Princeton	30
Frankfurt am Main	29
Mexico City	29
Vienna	29
Ho Chi Minh City	27
Izmir	26
Magnago	26
Helsinki	25
Lancaster	24
Nuremberg	24
Boston	23
Dearborn	23
Denver	22
Montreal	22
Elk Grove Village	21
Atlanta	19
Council Bluffs	19
Johannesburg	19
Phoenix	19
San Francisco	19
Brussels	17
Hanoi	17
Orem	17
San Diego	17
West Jordan	16
Buffalo	15
Rio de Janeiro	15
Stockholm	14
Belo Horizonte	13
Lappeenranta	13
Poplar	13
Amsterdam	12
Ankara	12
Assago	12
Turku	12
Pune	11
Sterling	11
Dulles	9
Düsseldorf	9
Manchester	9
Mumbai	9
Charlotte	8
Detroit	8
Dhaka	8
Dong Ket	8
New Delhi	8
Vancouver	8
Verona	8
Berlin	7
Falkenstein	7
Ottawa	7
Pittsburgh	7
Querétaro	7
San Jose	7
Shanghai	7
Brasília	6
Curitiba	6
Hounslow	6
Nairobi	6
Porto Alegre	6
São José do Rio Preto	6
Baghdad	5
Totale	7.154

Salva come PNG Salva come JPEG

Nome	#
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy	433
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	181
Coronaviridae and SARS-associated coronavirus strain HSR1.	174
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	166
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	165
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	156
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	149
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age	144
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	141
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	140
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	124
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	117
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	115
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	112
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	110
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	106
Phage display for the production of human monoclonal antibodies against human pathogens.	99
A biologically-validated HCV E1E2 heterodimer structural model	97
Humoral immune response against hepatitis C virus.	97
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	93
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	89
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	88
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	85
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	84
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	82
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	82
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	79
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	78
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	76
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	75
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	74
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	73
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	72
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	71
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	71
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series	70
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	69
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	68
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	68
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	68
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	67
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	66
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	66
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	65
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	65
Answer to photo quiz: Streptococcus pneumoniae	64
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	63
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	63
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	62
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	62
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	62
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	62
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	61
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	61
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	61
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	60
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	60
Viral respiratory pathogens and lung Injury	60
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	59
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	59
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	59
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	58
A closer look at prion strains: characterization and important implications	57
Type III interferons disrupt the lung epithelial barrier upon viral recognition	57
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	57
The interferon landscape along the respiratory tract impacts the severity of COVID-19	57
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023	56
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	56
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023	55
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	55
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	55
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	55
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	55
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects	54
Risks of "blind" automated identification systems in medical microbiology	54
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	54
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	54
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	53
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	53
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey	53
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2	53
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	53
Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates	52
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	52
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	52
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	52
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	51
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience	51
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols	51
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition	50
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era	50
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	50
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis	50
Interferon-β-1a inhibition of severe acute respiratory syndrome–Coronavirus 2 in vitro when administered after virus infection	50
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	49
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	49
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	49
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	49
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	48
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	48
Totale	7.805

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	66.085
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	66.085

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	131	0	0	0	0	0	20	18	17	29	6	16	25
2021/2022	219	11	43	20	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.699	371	395	336	500	572	254	23	55	79	66	12	36
2024/2025	3.254	24	58	629	141	102	159	134	134	353	184	465	871
2025/2026	3.369	594	409	616	987	541	222	0	0	0	0	0	0
Totale													10.941